Heartstart MRx Defibrillator, Model M3535A, M3536A - ANVISA Registry # 10216710136 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Philips Medical Systems 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1361
  • 날짜
    2014-02-14
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    You can continue to use the MRx prior to inspection and installation of the upgrade hardware by your Philips Authorized Service Provider once you receive the notification: • Ensure that you are performing continuous inspections of the treatment connection on all MRx devices to detect the wear. The HeartStart MRx Instructions for Use, 453564396411 Issue 1, 453564307761 Issue 2, or 453564174011, a "Maintenance and Inspection of Treatment Connection When Using in Transportation" circulation, Addendum, Edition 6, describe how users can identify wear . • If wear is detected, immediately remove affected devices from use and contact Philips to program the service. After receiving the inspection and updating of the hardware (if applicable) from Philips, continue to perform continuous inspection of the treatment connection in accordance with the HeartStart MRx Instructions for Use to detect any wear in the future. WARNING: The life of the treatment cables / outer blades is up to 3 years. To maintain performance reliably and to reduce the possibility of failure during patient use, replace them every three years from the time they are used or if they fail to meet the criteria for inspection of the Instructions for Use. there is a potential that one or more of the following items may occur. • Delay in treatment • Incorrect energy distribution • Spontaneous / unintentional treatment energy discharge • Shock healthcare professional when administering treatment • Interruption of stimulation with loss of catch and inability to recapture.
  • 원인
    When used in hospital or pre-hospital transport (emergency medical support), the connection between the pad therapy cable (including the cardiopulmonary resuscitation pad therapy cable, external pad cable and internal pad adapter cables / adapters ) and the inlet of the mrx connection may present high levels of stress, causing accelerated wear. connection wear can prevent the device from detecting that the blade handling cable is connected. this wear may also cause the mrx to inappropriately identify the handling handle for blades, outer blades, or inner blades. the wear of the treatment cable of the birds and the treatment connection inlet may present a risk to patients and / or health professionals.
  • 조치
    Software Update, parts / parts correction

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    ANVSANVISA